Discontinued — last reported Q3 '25
DexCom Deferred Tax Assets increased by 0.2% to $296.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 39.2%, from $487.30M to $296.10M. Over 4 years (FY 2021 to FY 2025), Deferred Tax Assets shows an upward trend with a 15.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase can signal future tax efficiency or the utilization of past losses, while a decrease may indicate the realization of those benefits.
These are assets on the balance sheet that represent future tax savings resulting from temporary differences between the...
Common in large, capital-intensive companies; peers with significant R&D spending often have large deferred tax assets from tax credits.
deferred_tax_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $216.40M | $216.30M | $290.50M | $290.80M | $309.50M | $342.30M | $341.20M | $349.10M | $4.80M | $4.60M | $419.40M | $460.70M | $475.80M | $486.50M | $481.20M | $487.30M | $496.30M | $375.60M | $295.60M | $296.10M |
| QoQ Change | — | -0.0% | +34.3% | +0.1% | +6.4% | +10.6% | -0.3% | +2.3% | -98.6% | -4.2% | >999% | +9.8% | +3.3% | +2.2% | -1.1% | +1.3% | +1.8% | -24.3% | -21.3% | +0.2% |
| YoY Change | — | — | — | — | +43.0% | +58.3% | +17.5% | +20.0% | -98.4% | -98.7% | +22.9% | +32.0% | >999% | >999% | +14.7% | +5.8% | +4.3% | -22.8% | -38.6% | -39.2% |